Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal PengabdianMu: Jurnal Ilmiah Pengabdian kepada Masyarakat JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
Purba, Abdul Khairul Rizki
Unknown Affiliation
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Economics, Econometrics & Finance Immunology & microbiology Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Neuroscience Public Health Social Sciences

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Peningkatan Kemampuan Literasi Pemanfaatan Simplisia Tanaman Obat Herbal untuk Kesehatan Keluarga: Improvement of Literacy Skills in the Utility of Herbal Simplicia Medicine for Family Health Purba, Abdul Khairul Rizki; Sakina, Sakina; Hasanatuludhhiyah, Nurina; Fatimah, Nurmawati; Paramitha, Nabilah; Mukhoirotin, Mukhoirotin; Toyib, Muchammad
PengabdianMu: Jurnal Ilmiah Pengabdian kepada Masyarakat Vol. 9 No. 9 (2024): PengabdianMu: Jurnal Ilmiah Pengabdian kepada Masyarakat
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/pengabdianmu.v9i9.6971

Abstract

Indonesia has a variety of plants with various health benefits. Communities in small linkages such as families, RT, and RW can utilize family medicinal plants (TOGA) to maintain stamina so that immunity remains optimal. Educational efforts to utilize TOGA simplisia were carried out in the form of community service in Sumorame, Candi District, Sidoarjo Regency. A total of 38 participants attended the training. The methods used in this activity include counseling and workshops. The knowledge domain of traditional medicine increased by 47.6 points higher than the pretest. A total of 26 participants (68.4%) stated that they often used TOGA. The reasons for using TOGA include natural remedies (n = 22; 57.9%), maintaining stamina and health (n = 12; 31.6%), and first aid when sick before seeing a doctor (n = 4; 10.5%). During the training, participants mentioned 2 to 6 parts of TOGA with their properties. Participants received information about TOGA and its utilization from social media (15%), and mass media (10-14%). The information sources from academics are still low (3%). The community has the potential to use TOGA which can be considered to maintain health in the long term. They already know its utilization from generations and mass media information. Continuous education by academics and health workers is needed for public health and to drive the economy.
Cost-Effectiveness Analysis of Taxane-Based and Anthracycline-Based Chemotherapy in Stage 4 Breast Cancer Patients at Dr. Soetomo General Hospital, Surabaya, Indonesia Sabrina, Adele; Purba, Abdul Khairul Rizki; Ardhiansyah, Azril Okta; d’Arqom, Annette
JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga Vol. 17 No. 1 (2026): JANUARY 2026 (IN-PROGRESS ISSUE)
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/juxta.V17I12026.43-48

Abstract

Highlights: Epirubicin (anthracycline-based) showed the highest cost-effectiveness. Taxane-based regimens were less cost-effective compared with anthracyclines.   Abstract Introduction: Breast cancer, particularly stage 4, contributes significantly to global morbidity and mortality. Anthracycline- and taxane-based chemotherapies are commonly used for metastatic breast cancer, but their high costs necessitate a cost-effectiveness analysis to inform healthcare financing. This study aimed to assess the cost-effectiveness of these therapies in stage 4 breast cancer patients at Dr. Soetomo General Hospital, Surabaya, Indonesia. Methods: A retrospective review of medical records from 124 stage 4 breast cancer patients treated in inpatient and outpatient settings was conducted. Effectiveness rates and cost data for epirubicin, doxorubicin, docetaxel, and paclitaxel were analyzed. Data processing involved basic calculations in Google Sheets, and the Average Cost-Effectiveness Ratio (ACER) and Incremental Cost-Effectiveness Ratio (ICER) were calculated. Ethical clearance was obtained. Results: Epirubicin was the most cost-effective, with an ACER of IDR 958,878 and an ICER of -IDR 2,603,667. Conclusion: Epirubicin is the most cost-effective chemotherapy option for stage 4 breast cancer, supporting its use in resource-limited settings and guiding cancer therapy decisions.
Co-Authors Annette d’Arqom, Annette Ardhiansyah, Azril Okta Fatimah, Nurmawati Mukhoirotin Mukhoirotin Nurina Hasanatuludhhiyah Paramitha, Nabilah Sabrina, Adele Sakina Sakina, Sakina Toyib, Muchammad